HOSAKA Tetsuya | Department of Hepatology, Toranomon Hospital

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
The Efficacy of Interferon-beta Monotherapy for Elderly Patients with Type C Hepatitis of Genotype 2
Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses
Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus
Hepatocarcinogenesis Following HCV RNA Eradication by Interferon in Chronic Hepatitis Patients
The Efficacy of Short-Term Interferon-Beta Therapy for Type C Cirrhotic Patients with Genotype 2a and Low Virus Load
Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine
Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma : a pilot study of patients with hepatitis B virus-related cirrhosis
Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection
Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter
Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis
Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan
Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001
Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment
Factors contributing of ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C
Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis
Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection
Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy
Successful control of ruptured hepatocellular carcinoma with radiofrequency ablation
Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia
Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma : differences between young and elderly patients
Changes in viral loads of lamivudine-resistant mutants during entecavir therapy
Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2
Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load
Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection
High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load
Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine
Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus
Clinical features of hepatitis B virus genotype A in Japanese patients
A Pilot Study of Thymosin α_1 Therapy for Chronic Hepatitis B Patients
Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma : a longterm cohort study of 892 patients with viral cirrhosis
Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants
Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks
Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment
New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma
Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation : A retrospective study of hepatitis C virus-related liver cancer
Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus
Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan

もっと見る

スポンサーリンク